Toshinori Sato Selected Research

GD1a ganglioside

8/2011	Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells.
8/2010	Ganglioside GD1a suppression of NOS2 expression via ERK1 pathway in mouse osteosarcoma FBJ cells.
6/2008	Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshinori Sato Research Topics

Disease

8	Infections 07/2018 - 12/2002
8	Experimental Melanoma 08/2011 - 08/2005
7	Osteosarcoma (Osteogenic Sarcoma) 01/2013 - 07/2006
6	Human Influenza (Influenza) 01/2022 - 06/2010
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2008
6	Neoplasms (Cancer) 01/2020 - 07/2006
4	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2020 - 12/2002
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Influenza in Birds (Avian Flu) 01/2020
1	Lewis Lung Carcinoma 09/2012
1	Insulin Resistance 05/2012
1	Embryonal Carcinoma 03/2011
1	Neuroblastoma 11/2010
1	Hepatocellular Carcinoma (Hepatoma) 07/2006

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2006
8	Peptides (Polypeptides)IBA 01/2022 - 07/2009
7	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 07/2009
6	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2012
5	GangliosidesIBA 01/2022 - 08/2010
4	Caveolin 1IBA 09/2012 - 07/2006
3	sialyloligosaccharide receptorIBA 01/2020 - 01/2016
3	OligosaccharidesIBA 11/2012 - 08/2005
3	GD1a gangliosideIBA 08/2011 - 06/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 01/2007
2	LigandsIBA 07/2018 - 03/2016
2	LipidsIBA 01/2018 - 09/2009
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2016 - 06/2010
2	Biological ProductsIBA 10/2014 - 12/2008
2	serinamideIBA 01/2013 - 11/2012
2	GlycosaminoglycansIBA 01/2013 - 11/2012
2	Polysaccharides (Glycans)IBA 01/2013 - 11/2012
2	Messenger RNA (mRNA)IBA 08/2011 - 07/2006
2	GlycosphingolipidsIBA 03/2011 - 11/2010
2	G(M3) GangliosideIBA 09/2009 - 05/2007
2	Complementary DNA (cDNA)IBA 05/2007 - 07/2006
1	EnzymesIBA 01/2022
1	Protein AggregatesIBA 01/2022
1	PolymersIBA 01/2022
1	BoronIBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	DiamondIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Thymidine KinaseIBA 08/2017
1	SugarsIBA 03/2016
1	Neuraminidase (Sialidase)IBA 01/2016
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2016
1	Dendrimers (Dendrons)IBA 10/2014
1	heparanaseIBA 01/2013
1	Insulin (Novolin)FDA Link 05/2012
1	Detergents (Detergent)IBA 05/2012
1	G(M1) GangliosideIBA 05/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2011
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 08/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2011
1	BucladesineIBA 03/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2010
1	Antiviral Agents (Antivirals)IBA 06/2010
1	Ether (Diethyl Ether)IBA 10/2009
1	Membrane LipidsIBA 09/2009
1	Cell Surface ReceptorsIBA 07/2009
1	sialooligosaccharidesIBA 07/2009
1	Glycoproteins (Glycoprotein)IBA 07/2009
1	GlycolipidsIBA 07/2009
1	Amyloid beta-PeptidesIBA 12/2008
1	peptide P3IBA 09/2007
1	Cholera ToxinIBA 09/2007
1	N-Acetyllactosamine SynthaseIBA 05/2007
1	Glucosylceramides (Glucocerebrosides)IBA 05/2007
1	Uridine Diphosphate (UDP)IBA 05/2007
1	Cytidine Monophosphate (CMP)IBA 05/2007
1	Small Interfering RNA (siRNA)IBA 05/2007
1	haematoside synthetaseIBA 05/2007
1	Stromal Interaction Molecule 1IBA 01/2007
1	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 07/2006
1	VitronectinIBA 07/2006
1	lactosidesIBA 08/2005
1	adenovirus receptorIBA 12/2002
1	ChitosanIBA 12/2002
1	arginyl-glycyl-aspartic acidIBA 12/2002
1	integrin beta5IBA 12/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 06/2010
1	Electrodes (Electrode) 01/2020